| Literature DB >> 26997941 |
Ron Hochstenbach1, Beata Nowakowska2, Marianne Volleth3, Amber Ummels1, Anna Kutkowska-Kaźmierczak2, Ewa Obersztyn2, Kamila Ziemkiewicz2, Claudia Gerloff4, Denny Schanze3, Martin Zenker3, Petra Muschke3, Ina Schanze3, Martin Poot1, Thomas Liehr5.
Abstract
We present 2 cases with multiple de novo supernumerary marker chromosomes (sSMCs), each derived from a different chromosome. In a prenatal case, we found mosaicism for an sSMC(4), sSMC(6), sSMC(9), sSMC(14) and sSMC(22), while a postnatal case had an sSMC(4), sSMC(8) and an sSMC(11). SNP-marker segregation indicated that the sSMC(4) resulted from a maternal meiosis II error in the prenatal case. Segregation of short tandem repeat markers on the sSMC(8) was consistent with a maternal meiosis I error in the postnatal case. In the latter, a boy with developmental/psychomotor delay, autism, hyperactivity, speech delay, and hypotonia, the sSMC(8) was present at the highest frequency in blood. By comparison to other patients with a corresponding duplication, a minimal region of overlap for the phenotype was identified, with CHRNB3 and CHRNA6 as dosage-sensitive candidate genes. These genes encode subunits of nicotinic acetylcholine receptors (nAChRs). We propose that overproduction of these subunits leads to perturbed component stoichiometries with dominant negative effects on the function of nAChRs, as was shown by others in vitro. With the limitation that in each case only one sSMC could be studied, our findings demonstrate that different meiotic errors lead to multiple sSMCs. We relate our findings to age-related aneuploidy in female meiosis and propose that predivision sister-chromatid separation during meiosis I or II, or both, may generate multiple sSMCs.Entities:
Keywords: CHRNA6; CHRNB3; Dominant negative effect; Maternal meiotic segregation error; Mental retardation; Multiple supernumerary marker chromosomes; Nicotinic acetylcholine receptors; Predivision chromatid separation
Year: 2015 PMID: 26997941 PMCID: PMC4772618 DOI: 10.1159/000441408
Source DB: PubMed Journal: Mol Syndromol ISSN: 1661-8769